Physician profile
Chereen M Stroup
NPI 1457385742
$382.27
in general payments reported to CMS, 2019-2025
13 companies · $59.85 in 2025
The $59.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.95 · 2020: $37.24 · 2021: $74.37 · 2022: $22.14 · 2023: $18.22 · 2024: $91.50 · 2025: $59.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $77.84 | 2020-2021 | |
| Pfizer INC. | $46.54 | 2019-2020 | |
| Abbott Laboratories | $42.15 | 2024-2025 | Freestyle Libre 3 |
| Amgen INC. | $29.62 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $29.20 | 2024 | Voquezna |
| Abbvie INC. | $24.92 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $23.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.14 | 2022 | |
| Lundbeck LLC | $21.02 | 2025 | Rexulti |
| Organon LLC | $18.22 | 2023 | Nexplanon |
| Inspire Medical Systems, INC. | $17.77 | 2025 | Inspire |
| Lilly USA, LLC | $16.29 | 2024 | Zepbound |
| Allergan, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chereen Stroup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.